Pharos Generics' Minority Stake Acquired by Armira and Viessmann
Deal News | Nov 07, 2024 | CEE Legal Matters
Germany-based Armira and Viessmann Generations Group have successfully acquired a minority stake in the Greek pharmaceutical company, Pharos Generics Holding. This acquisition was facilitated by Papapolitis & Papapolitis and White & Case for the buyers, while Pharos Generics and the sellers – Diorama Investments, Limonilum, Amarilenco, and Hesperiada – were advised by KLC and Zepos & Yannopoulos, with Latham & Watkins serving as international counsel for the sellers. Diorama Investments, a private equity fund managed by Deca Investments AIFM, divested the stake as part of this transaction, highlighting continued interest and investment in the pharmaceutical sector within Greece.
Sectors
- Pharmaceuticals
- Private Equity
Geography
- Greece – Pharos Generics Holding is based in Greece, and the transaction involves investment in the Greek pharmaceutical sector.
- Germany – Armira, a Germany-based investment holding company, is one of the key participants in the acquisition.
Industry
- Pharmaceuticals – Pharos Generics Holding operates within the pharmaceutical industry, focusing on drug manufacturing and distribution.
- Private Equity – The transaction involved several private equity entities, such as Armira and Diorama Investments, indicating active investment and divestment activity in the sector.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Pharos Generics Holding | Target | Company | A Greek pharmaceutical company involved in the production and distribution of generic drugs. |
| Armira | Buyer | Company | A Germany-based investment holding company acquiring a minority stake in Pharos Generics. |
| Viessmann Generations Group | Buyer | Company | A family business covering a range of industries, collaborating with Armira for the acquisition. |
| Diorama Investments | Seller | Company | A private equity fund managed by Deca Investments AIFM, selling its stake in Pharos Generics. |
| Limonilum | Seller | Company | One of the stakeholder companies selling a share in Pharos Generics. |
| Amarilenco | Seller | Company | Part of the seller group in the transaction with Pharos Generics. |
| Hesperiada | Seller | Company | Participating as a seller of its stake in Pharos Generics. |
| Papapolitis & Papapolitis | Legal Advisor | Company | Provided legal counsel to Armira and Viessmann on the acquisition deal. |
| White & Case | Legal Advisor | Company | Assisted Papapolitis & Papapolitis in advising Armira and Viessmann on the deal. |
| KLC | Legal Advisor | Company | Advised Pharos Generics Holding and the seller companies on the transaction. |
| Zepos & Yannopoulos | Legal Advisor | Company | Provided counsel to Diorama Investments on the sale. |
| Latham & Watkins | International Legal Counsel | Company | Served as international counsel for the sellers in the transaction. |